Isam Alobid
Research group
- Clinical and experimental respiratory immunoallergy Accredited researcher (R3A)
Featured publications
-
Paediatric Barcelona Olfactory Test-6 (pBOT-6): Validation of a Combined Odour Identification and Threshold Screening Test in Healthy Spanish Children and Adolescents
Authors:Reference: Journal Of Investigational Allergology And Clinical Immunology 2020. -
Olfactory Training Prevents Olfactory Dysfunction Induced by Bulbar Excitotoxic Lesions: Role of Neurogenesis and Dopaminergic Interneurons
Authors:Reference: Molecular Neurobiology 2019. -
Recovery of Olfactory Function After Excitotoxic Lesion of the Olfactory Bulbs Is Associated with Increases in Bulbar SIRT1 and SIRT4 Expressions
Authors:Reference: Molecular Neurobiology 2019. -
European position paper on diagnostic tools in rhinology
Authors:Reference: Rhinology 2019. -
Patient Advisory Board for Chronic Rhinosinusitis - A EUFOREA initiative
Authors:Reference: Rhinology 2019. -
The GALEN rhinosinusitis cohort: chronic rhinosinusitis with nasal polyps affects health-related quality of life
Authors:Reference: Rhinology 2019. -
Self-perception of olfactory dysfunction is associated with history of Traumatic Brain Injury: post-hoc analysis from the OLFACAT survey
Authors:Reference: Rhinology 2019. -
Modified nasal floor and inferior meatus flap for septal perforation repair. Extension and limits.
Authors:Reference: Rhinology. 2018. -
Olfactory Dysfunction in Neurodegenerative Diseases
Authors:Reference: Current Allergy And Asthma Reports 2018.
Featured Projects
-
Expression of Rupatadine on PAF-induced inflammation in blood eosinophils and epithelial cells from nasal polyps and healthy nasal mucosa (RINOPAF-2 Study).
Principal investigator: Joaquim Mullol I MiretFunder: URIACH S.ACode: RINOPAF-02-2018Duration: 01/01/2019 - 31/12/2021 -
El impacto de la inflamación sobre el sentido del olfato en pacientes con poliposis nasal: El rol de los eosinófilos sobre la neurogenesis del neuroepitelio olfatorio.
Principal investigator: Isam AlobidFunder: Fundació Privada Clínic per a la Recerca Biomèdica (Sede o evento); Fondo Investigaciones Sanitarias (FIS)Code: (PI15/00262)Duration: 01/01/2016 - 31/12/2019 -
Study of the antiinflammatory mechanisms of action of MP29-02, compared to fluticasone propionate and azelastine alone, in healthy and inflamed human ansal mucosa: regulation on anti- and pro-inflammatory genes and GR.
Principal investigator: Joaquim Mullol I MiretFunder: MEDA PharmaCode: DYMECOS IIDuration: 01/01/2016 - 31/12/2019 -
Randomized double-blind, phase III, placebo controlled, to evaluate dupilumab in patients with bilateral nasal polyposis and symptoms of chronic sinusitis.
Funder: Sanofi Aventis, S.A. ; CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER (Participante)Duration: 01/01/2016 -
Randomized double-blind, phase II, placebo controlled, 2 arm study to evaluate dupilumab in patients with bilateral nasal polyposis and symptoms of chronic sinusitis.
Funder: Sanofi Aventis, S.A. ; CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER (Participante)Duration: 01/01/2014